Abstract
system. Particularly useful reports of costs by Australian national diagnosis related group (AN-DRG) are now being generated in several States.
There are several types of uses. One is for the purpose of improving the product classifications themselves. At the level of the individual hospital, a more important application is to production management. Differences in costs per product relative to other hospitals or over time suggest potential problems in efficiency. A related use concerns internal contracting. It is becoming common in large hospitals to base (say) the obstetrics department budget on agreed prices per product, and to require it to purchase services from ancillary areas such as pathology and physiotherapy.
The fourth type of use has attracted the most interest until recently: that of external pricing. Results from studies like that reported here have been important in the context of casemix funding of public hospitals, and are similarly assisting refinement of contracts between private insurers and private hospitals.
The first serious Australian study of hospital costs for products defined by DRG took place in 1987, and involved major public hospitals in South Australia. Many other studies were conducted over the next five years which used similar methods but refined the details and made use of better data. Since then many individual hospitals, hospital groups, and State health authorities have established routine costing cycles.
The first major national study was conducted in 1992-93 (CDHFS 1994) . A stratified random sample of 97 hospitals with over 50 beds was used to estimate the mean total and component service costs of acute admitted patients classified by both AN-DRG versions 1 and 2. The costs of all other products were excluded. Each hospital provided its own cost data by cost centre, overhead cost allocation statistics, and product volumes. Almost all the final costs were allocated among DRGs by use of service weights derived from Maryland charges data. The only significant exception was use of nursing service weights derived from a sample of public hospitals in New South Wales and South Australia.
In 1995, the Commonwealth re-processed the 1992-93 data to create version 3 cost weights (CDHFS 1995) . One weakness was that the production data were out of date. However, there were some counterbalancing improvements. In particular, the 97 hospitals were given the opportunity to correct some of their original data, and the Maryland service weights were largely replaced by the results of Australian studies. Completely new service weights were developed for operating rooms (Deloitte Touche Tohmatsu 1995), diagnostic imaging (KPMG 1995a) , pathology (KPMG 1995b) and critical care (KPMG 1995c) . The nursing service weights were refined through addition of data from more public hospitals in NSW.
In 1996, the decision was taken to replicate the survey for the 1996-97 financial year, but with significant differences. Inter alia, there was no a priori sampling. Rather, every site which wished to participate would be supported, if it met standards for data systems. Second, the opportunity would be taken to broaden the scope of included products and costs. Third, improvements in methodology would be implemented. Finally, there would be a deliberate aim of establishing a routine process, rather than a one-off study. This has had important ramifications, including greater emphasis on local skills development and the establishment of methods having long-term validity, as opposed to precision of the first set of results.
Hospitals around Australia were invited to indicate their interest during early 1997, and 146 were selected as summarised in Table 1 . They were provided with detailed documentation (and costing software if they wished). Most hospitals chose to use a new variant of the Yale Cost Model called COMBO, and some used a similar product, COSMOS. National DRG service weights data were provided on disk for use as required. 
Private hospitals 22

Total in study 148
Training sessions for hospital staff were conducted in late 1997. During this and subsequent stages, they had ready access to expert advice from State and Territory coordinators, and to a private hospitals advisory team.
Method
The standard method of cost allocation was applied for the most part. First, all costs were identified for the entire operation of each participating hospital for the complete 1996-97 financial year, and amended as necessary to match the products in scope. As noted above, the emphasis was on validity. Sites were therefore encouraged to make best estimates of relevant costs which were missing from the accounting data (such as those relating to services provided by an offsite corporate or 'group' office), and similarly to exclude costs in the accounts relating to products out of scope (such as services to admitted patients at other hospitals).
Particular attention was given to the treatment of capital-related costs. Sites were asked to conform to a set of standards regarding such matters as depreciation, leases and rentals, licence and royalty fees, taxes, and return on investment. For example, they were asked to insert missing costs relating to any asset which continued to be used during the study period, even if it had been fully depreciated in the accounts.
Where revenue was generated by selling products outside the hospital, sites were asked not to offset revenues against costs but, rather, to remove the estimated costs. They were asked to impute costs of donated capital items even if this was not the accounting practice. It was decided, however, that there should be no imputation of 'notional' costs related to the provision of personal services free of charge (as in the case of volunteers who assist with hospital activities).
Some rules related for the most part to private hospitals. For example, it was common practice for prostheses costs to be missing from the hospital's accounts where they had been acquired by patients or their doctors. In these cases, the hospital was asked to estimate the missing costs by type of prosthesis.
Once the starting costs had been adjusted in these and other ways, they were distributed in the second stage to cost centres defined to be either overhead or final product. Costs of the latter are able to be associated with final products (patient care episodes), whereas the former provide their services to other cost centres. Participating sites were encouraged to refine their cost centre structures to approximate a standard list.
As a minimum, they were required to indicate two attributes of each cost centre: the type of input (such as equipment or nursing), and the type of product (acute admitted patient, rehabilitation, and so on). This was an improvement on the previous national study, where analytical teams often had to guess the cost types from cost centre names.
Third, the overhead costs were fully distributed among the final product cost centres using the standard matrix multiplication technique. An improved set of minimum standard cost allocation statistics was incorporated.
Fourth, costs were tracked from the final product cost centres to final products, which constituted a refined set relative to the first national study. Eight major product types were defined. The most important, acute admitted patients, were to be sub-categorised by the most recent AN-DRG version (3.1). In a few private hospitals, the separations were also sub-categorised by the CMBS procedure classification.
The remaining major product types (rehabilitation admitted patient, palliation admitted patient, non-acute admitted patient, non-admitted patient, research, and teaching) were required to be reported only in terms of total and component costs without sub-categorisation. No details about volumes were required, excepting total admissions. It was recognised that the cost data might not be accurate. However, it was considered to be worthwhile to make best estimates, if only to minimise the extent to which the DRG costing results were polluted by the retention of other episodes or costs.
Products were defined according to national standards where they existed. For example, the definitions of patient care types contained in the National Health Data Dictionary were applied. In accordance with the dictionary, psychiatric admitted patient episodes were distributed among the four categories in the same way as all other types of health problems.
Statistical separation rules were applied. Many participating hospitals had not, in fact, been fully applying these rules during 1996-97. We asked hospitals to make the best possible estimates, and to adjust the discharge data accordingly. All hospitals were required to provide a computer file containing all separations during 1996-97 in which all records were to be coded to indicate whether they were acute, rehabilitation, palliation or non-acute.
Many hospitals relied almost exclusively on the improved national service weights. However, increased use was made of locally developed allocation statistics. They ranged from service weights to patient-level statistics derived from the use of both local relative value unit scales for intermediate products and consumption data.
Some sites used a mix of patient consumption data and service weights. A few made extensive use of locally developed allocation statistics at the level of individual patient care episodes, and therefore submitted their results in the form of a patient-level file. They tended to be hospitals using commercial software packages like Trendstar and Transition, because they had chosen to establish a routine process of costing of individual episodes.
Participating sites were required to provide their results in a standard format. They also provided various sets of key source data files so that their results could be checked and additional analyses undertaken by the Commonwealth team (including the development of cost weights for AN-DRG version 4 when it becomes available).
Overview of the results
The results are fully reported elsewhere, and are available on disk (CDHFS 1998). Here, we will merely illustrate the data structure and discuss a few aspects of precision.
The main kind of report is illustrated in Tables 2 to 5. Table 2 shows mean costs per separation for the top 20 AN-DRGs by volume in the public hospital sector. The standard error of the estimated cost weight is reported in the same way as in previous national studies (CDHFS 1993) for the purpose of comparison. The number of cases is the estimated national total, by inflation of the sample. Component costs for public hospitals are shown in Table 3 for the top 7 ANDRGs. Unlike the 1992-93 study, overheads are reported separately for each component. Tables 4 and 5 show the same data for private hospitals.
As shown in Table 2 , the mean cost per acute admitted patient was $2275 for public hospitals in 1996-97, compared with $2454 in 1994-95. Table 4 shows the mean was $2060 for private hospitals in 1996-97 (compared with $1671 in 1994-95).
The reported fall in mean costs in public hospitals probably reflects two main factors. First, they have become more efficient. Second, they have also changed their methods of cost measurement and attribution. Inter alia, they have improved with respect to statistical separation (thus splitting more episodes into two), and they have more completely removed the non-DRG costs such as teaching and research.
The reported increase in private hospitals is probably a consequence of two quite different factors. First, they continue to increase the range and complexity of patients treated. Second, they appear to have tended to include a greater range of costs than in 1992-93. In particular, they have more precisely handled capitalrelated, prosthesis, and diagnostic services costs. There was significant underreporting in the 1992-93 survey. Most of the results appear to be plausible. For example, the cost relativities between related AN-DRGs were much as expected, as illustrated by the subset of obstetrics classes shown in Figure 6 . There are increases in proportion to complexity, in both the private and the public hospitals. The same pattern is present for mean length of stay (LOS) excepting that, for private hospitals, AN-DRG 677 has a shorter LOS but higher cost than AN-DRG 676. This is presumably because of the higher fixed costs in operating rooms. The statistics are reversed for the public hospitals, but the cost weights (1.04 compared with 1.54) are further apart. The opportunity was taken to check the results against those of other studies where possible. An example is presented in Figure 7 , with respect to the recently released results of the National Pharmacy Bridging Project (SHPA 1998). There were differences of scope and definition, and there is a satisfactory degree of correlation between the Bridging Project and the public hospital results in the circumstances. However, private hospital costs are understated. The main reason is that many pharmacy costs are not recorded in the private hospital's accounts because they are financed in other ways (for example, through direct payment by a private insurer to a pharmacy service provider not part of the hospital accounting entity).
There are several areas in which data problems appear to have affected the precision of the results. In some cases, there is simply no solution at present. Most obvious, the allocation of medical costs is largely a matter of imputation through the use of crude correlates because no data systems exist which record what doctors do.
In other cases, there is reason to believe better use could have been made of available data. The costs of critical care services seem to be of doubtful precision overall. An example is AN-DRG 674 (vaginal delivery without complications) which has a nonzero critical care cost although it is difficult to imagine cases where critical care was needed but there were no significant complications.
The prosthesis cost data are presumably inaccurate. For example, public hospitals have probably under-reported these costs and failed to attribute them correctly across AN-DRGs. Private hospital data are even more implausible. Examples are the AN-DRGs involving AICD implant, where the reported mean costs are probably underestimated by at least a factor of 2. In spite of instructions, many hospitals obviously failed to estimate costs of prostheses where they were acquired by the doctor (and consequently not recorded in the hospital's accounts).
In other areas, apparently inaccurate results are probably a consequence of underlying weaknesses in the casemix model itself. For example, operating room costs appear to be relatively precise overall, but there are problems with respect to medical AN-DRGs (such as 453, 454, and 455) where a subset (of varying size across hospitals) would appropriately receive OR services.
Another category of problems derives from variations in care settings. For example, allied health professional costs are affected by differences between hospitals in terms of the extent to which care is provided during the admission rather than on an ambulatory basis after discharge. There may also be avoidable weaknesses in the case of allied health. It is evident that the less precise unconditional service weights have been used, when there were presumably some data on actual patient contacts which would have supported the use of conditional service weights.
Discussion
For the reasons outlined above, the results need to be used with caution. However, initial checks suggest they are of greater precision overall than those from the 1992-93 study. They have the additional advantage of reflecting more recent clinical practice.
An important improvement is the more useful disaggregation of costs. For example, separate reporting of salary oncosts (which include expenses as workers' compensation, payroll tax and superannuation) allows account to be taken of State and sector (public, private for profit, private nonprofit) differences which are significant and largely outside the control of the individual hospital.
Some methodological issues have been clarified. One is the long-time debate about the merits of cost modelling (typified by the use of service weights and lowcost software) and patient costing (typified by the use of more expensive software and local consumption data). The debate has often involved confusion over three largely unrelated issues: the software's capabilities, the use of service weights or locally generated RVU and consumption data, and the data requirements of managers.
We have demonstrated that, although the various software packages vary in many respects, they allocate costs in much the same way and their outputs are compatible. Similarly, we have shown that a mix of patient costing and service weight data can be combined. We intend to explore the extent to which differences in cost allocation methods have affected the precision of the results.
The last issue is the most difficult to address: at what level of precision should products be costed? We believe there is no single answer, and it will depend on local circumstances and intended uses. Routine costing at the individual patient level has some obvious advantages, but involves large initial and maintenance costs. We suspect that some hospitals may have overestimated the advantages if the main objective is simply to manage a hospital. For most kinds of management purposes, estimation of the average cost for a class of patients is the most sensible goal. Managers do not have the time to worry about the costs of individual patients.
We believe it is important to calculate national averages on a routine basis. One consideration is that national statistics help us to move towards equity of access to quality services, which is a key community goal. Another factor is recognition of the practical benefits: Australia is too small to allow good estimates to be made of the costs of many low-volume case types at the State level or below.
A related conclusion is that it is essential to measure costs using a national standard methodology. We need to establish a routine annual cycle of updated costs, which reflects the continual changes in hospital input prices and clinical practice. This can only be done well if a valid standard methodology is applied as soon as possible. Some of the current differences between States are justified by variations in local needs and data collection capabilities. However, it should be possible to establish national standards without prejudice to other needs.
The national cost data collection should not be an expensive task. The key is reliance on by-product data. At the level of the individual hospital, the data for costing should largely be the by-products of care provision and routine accounting. The national collection should in turn depend on aggregating those data captured by individual hospitals. There are significant savings if the process is ongoing, in that many one-off costs are avoided. Moreover, errors will be more easily found and rectified if there is a series of annual results based on a stable (albeit progressively refined) methodology.
